Zusammenfassung
Erstmalig wurde die altersabhängige Makuladegeneration (AMD) im Jahre 1885 als ein eigenständiges klinisches Krankheitsbild mit altersabhängiger Pigmentverschiebung und atrophischen Veränderungen des zentralen Netzhautbereiches (Makula) beschrieben [28]. Heute gilt die AMD als eine der häufigsten Netzhauterkrankungen in den Industrienationen und als Hauptursache für gesetzlich anerkannte Blindheit [21]. In den letzten Jahrzehnten wurden große Anstrengungen unternommen, die zugrunde liegenden Pathomechanismen der AMD aufzuklären. Zahlreiche klinisch-pathologische und experimentelle Beobachtungen führten zu ersten Konzepten einer AMD-Pathogenese, die darauf abzielen, mögliche Prozesse ausgehend von einer normalen, alternden Netzhaut bis hin zu manifesten Stadien der Erkrankung zu erklären [80].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Allikmets R (2000) Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 67:487–491
Allikmets R, Shroyer NF, Singh N, et al. (1997) Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277:1805–1807
Allikmets R, Singh N, Sun H, et al. (1997) A photoreceptor cellspecific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15:236–246
An E, Sen S, Park SK, Gordish-Dressman H, Hathout Y (2010) Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. Invest Ophthalmol Vis Sci (in press)
Baird PN, Hageman GS, Guymer RH (2009) New era for personalized medicine: the diagnosis and management of age-related macular degeneration. Clin Experiment Ophthalmol 37:814–821
Baird PN, Guida E, Chu DT, Vu HT, Guymer RH (2004) The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 45:1311–1315
Baum L, Chan WM, Li WY, et al. (2003) ABCA4 sequence variants in Chinese patients with age-related macular degeneration or Stargardt’s disease. Ophthalmologica 217:111–114
Botto M, Fong KY, So AK, Koch C, Walport MJ (1990) Molecular basis of polymorphisms of human complement component C3. J Exp Med 172:1011–1017
Cameron DJ, Yang Z, Gibbs D, et al. (2007) HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 6:1122–1125
Chan CC, Shen D, Zhou M, et al. (2007) Human HtrA1 in the archived eyes with age-related macular degeneration. Trans Am Ophthalmol Soc 105:92–97; discussion 97–98
Chen LJ, Liu DTL, Tam POS, et al. (2006) Association of complement factor H polymorphisms with exudative age-related macular degeneration. Molecular vision 12:1536–1542
Chen W, Stambolian D, Edwards AO, et al. (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 107:7401–7406
Chien J, Staub J, Hu SI, et al. (2004) A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene 23:1636–1644
Clark SJ, Higman VA, Mulloy B, et al. (2006) His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-diseaseassociated form. J Biol Chem 281:24713–24720
Conley YP, Jakobsdottir J, Mah T, et al. (2006) CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 15:3206–3218
Despriet DDG, van Duijn CM, Oostra BA, et al. (2009) Complement component C3 and risk of age-related macular degeneration. Ophthalmology 116:474–480
Dewan A, Liu M, Hartman S, et al. (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314:989–992
Edwards AO, Ritter R, 3rd, Abel KJ, et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421–424
Fisher SA, Abecasis GR, Yashar BM, et al. (2005) Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet 14:2257–2264
Francis PJ, Appukuttan B, Simmons E, et al. (2008) Rhesus Monkeys and Humans Share Common Susceptibility Genes for Age-Related Macular Disease. Hum Mol Genet 17: 2673–2680
Friedman DS, O’Colmain BJ, Munoz B, et al. (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564–572
Fritsche LG, Loenhardt T, Janssen A, et al. (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40:892–896
Fritsche LG, Freitag-Wolf S, Bettecken T, et al. (2009) Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene. Hum Mutat 30:1048–1053
Giannakis E, Male DA, Ormsby RJ, et al. (2001) Multiple ligand binding sites on domain seven of human complement factor H. Int Immunopharmacol 1:433–443
Gold B, Merriam JE, Zernant J, et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38:458–462
Gotoh N, Nakanishi H, Hayashi H, et al. (2009) ARMS2 (LOC387715) variants in Japanese patients with exudative agerelated macular degeneration and polypoidal choroidal vasculopathy. American journal of ophthalmology 147:1037–1041, 1041. e1031–1032
Grau S, Richards PJ, Kerr B, et al. (2006) The role of human HtrA1 in arthritic disease. J Biol Chem 281:6124–6129
Haab O (1885) Erkrankungen der Macula Lutea. Zentralbl Augenheilkd 9:384–391
Haddad S, Chen CA, Santangelo SL, Seddon JM (2006) The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 51:316–363
Hadley D, Orlin A, Brown G, et al.) Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26. Invest Ophthalmol Vis Sci 51:2191–2196
Hageman GS, Hancox LS, Taiber AJ, et al. (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Annals of medicine 38:592–604
Hageman GS, Anderson DH, Johnson LV, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102:7227–7232
Haines JL, Hauser MA, Schmidt S, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419–421
He X, Ota T, Liu P, et al.) Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells. Cancer Res 70:3109–3118
Hecker LA, Edwards AO, Ryu E, et al. (2010) Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum Mol Genet 19:209–215
Heinen S, Hartmann A, Lauer N, et al. (2009) Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114:2439–2447
Hughes AE, Orr N, Esfandiary H, et al. (2006) A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38:1173–1177
Jakobsdottir J, Conley YP, Weeks DE, Ferrell RE, Gorin MB (2008) C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PloS one 3:e2199
Jakobsdottir J, Conley YP, Weeks DE, et al. (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77:389–407
Johnson PT, Betts KE, Radeke MJ, et al. (2006) Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A 103:17456–17461
Kanda A, Chen W, Othman M, et al. (2007) A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A 104:16227–16232
Klaver CC, Kliffen M, van Duijn CM, et al. (1998) Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63:200–206
Klein RJ, Zeiss C, Chew EY, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385–389
Kortvely E, Hauck SM, Duetsch G, et al. (2010) ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Invest Ophthalmol Vis Sci 51:79–88
Ku CS, Loy EY, Pawitan Y, Chia KS) The pursuit of genome-wide association studies: where are we now? J Hum Genet 55:195–206
Laine M, Jarva H, Seitsonen S, et al. (2007) Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol 178:3831–3836
Li M, Atmaca-Sonmez P, Othman M, et al. (2006) CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38:1049–1054
Mahley RW, Rall SC, Jr. (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507–537
Maller J, George S, Purcell S, et al. (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38:1055–1059
McKay GJ, Dasari S, Patterson CC, Chakravarthy U, Silvestri G (2010) Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort. Mol Vis 16:194–199
Montes T, Tortajada A, Morgan BP, Rodriguez de Cordoba S and Harris CL (2009) Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proc Natl Acad Sci U S A 106:4366–4371
Mori K, Gehlbach PL, Kabasawa S, et al. (2007) Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population. Investigative ophthalmology & visual science 48:5315–5319
Oka C, Tsujimoto R, Kajikawa M, et al. (2004) HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 131:1041–1053
Penfold PL, Killingsworth MC, Sarks SH (1985) Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 223:69–76
Ricci F, Zampatti S, D’Abbruzzi F, et al. (2009) Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population. Archives of ophthalmology 127:1368–1372
Rivera A, Fisher SA, Fritsche LG, et al. (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14:3227–3236
Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41:355–367
Ross RJ, Bojanowski CM, Wang JJ, et al. (2007) The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Investigative ophthalmology & visual science 48:1128–1132
Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ (2007) A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 125:55–62
Schmid-Kubista KE, Tosakulwong N, Wu Y, et al. (2009) Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration. Invest Ophthalmol Vis Sci 50:5070–5079
Schmidt S, Saunders AM, De La Paz MA, et al. (2000) Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol Vis 6:287–293
Schmidt S, Klaver C, Saunders A, et al. (2002) A pooled casecontrol study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 23:209–223
Schork NJ, Murray SS, Frazer KA, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19:212–219
Schultz DW, Klein ML, Humpert A, et al. (2003) Lack of an association of apolipoprotein E gene polymorphisms with familial agerelated macular degeneration. Arch Ophthalmol 121:679–683
Seddon JM, Cote J, Page WF, Aggen SH, Neale MC (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123:321–327
Shroyer NF, Lewis RA, Yatsenko AN, Wensel TG, Lupski JR (2001) Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and agerelated macular degeneration. Hum Mol Genet 10:2671–2678
Simonelli F, Margaglione M, Testa F, et al. (2001) Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res 33:325–328
Skerka C, Zipfel PF (2008) Complement factor H related proteins in immune diseases. Vaccine 26 Suppl 8:I9–14
Skerka C, Lauer N, Weinberger AA, et al. (2007) Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immunol 44:3398–3406
Souied EH, Benlian P, Amouyel P, et al. (1998) The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125:353–359
Spencer KL, Hauser MA, Olson LM, et al. (2007) Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Human molecular genetics 16:1986–1992
Spencer KL, Olson LM, Anderson BM, et al. (2008) C3 R102G polymorphism increases risk of age-related macular degeneration. Hum Mol Genet 17:1821–1824
Strittmatter WJ, Saunders AM, Schmechel D, et al. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977–1981
Thakkinstian A, Bowe S, McEvoy M, Smith W, Attia J (2006) Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis. Am J Epidemiol 164:813–822
Wang G, Spencer KL, Court BL, et al. (2009) Localization of agerelated macular degeneration-associated ARMS2 in cytosol, not mitochondria. Invest Ophthalmol Vis Sci 50:308–-3090
Yang Z, Camp NJ, Sun H, et al. (2006) A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314:992–993
Yang Z, Tong Z, Chen Y, et al. (2010) Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration. PLoS genetics 6:e1000836
Yates JRW, Sepp T, Matharu BK, et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. The New England journal of medicine 357:553–561
Yu J, Wiita P, Kawaguchi R, et al. (2007) Biochemical analysis of a common human polymorphism associated with age-related macular degeneration. Biochemistry 46:8451–8461
Zarbin MA (2004) Current concepts in the pathogenesis of agerelated macular degeneration. Arch Ophthalmol 122:598–614
Zareparsi S, Reddick AC, Branham KE, et al. (2004) Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 45:1306–1310
Zareparsi S, Branham KE, Li M, et al. (2005) Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77:149–153
Neale BM, Fagerness J, Reynolds R, Sobrin L, et al. (2010) Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A 107:7395–400
Chen W, Stambolian D, Edwards AO, et al. (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 107:7401–6
Fagerness J, Maller JB, Neale BM, et al. (2009) Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 17:100–104
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Friedrich, U., Fritsche, L.G., Weber, B.H.F. (2011). Genetik. In: Altersabhängige Makuladegeneration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20870-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-20870-6_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20869-0
Online ISBN: 978-3-642-20870-6
eBook Packages: Medicine (German Language)